Instrument Inactif

Gouvernance Constellation Pharmaceuticals, Inc.

CNST

US2103731061

Recherche biotechnologique et médicale

Comité Exécutif: Constellation Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Brenda J. Sousa

62 ans

Human Resources Officer

01/03/2010

Kia Khalaghpour

Investor Relations Contact	-
Public Communications Contact	-

John McKenna

President

Composition du Conseil d'Administration: Constellation Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

John McKenna

Director/Board Member

Kathleen Warnecke

Director/Board Member

15/07/2021

Anciens Dirigeants et Administrateurs: Constellation Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Katarina Luptakova

Corporate Officer/Principal

01/04/2020

01/10/2021

Sarah Coughlin

Private Equity Investor

01/02/2019

01/10/2021

Richard Mountfield

General Counsel

01/07/2020

01/10/2021

Brendan Delaney

Corporate Officer/Principal

11/01/2021

01/09/2021

Mohan Bala

Chief Operating Officer	01/11/2019	01/09/2021
Corporate Officer/Principal	01/11/2019	01/11/2020

Jigar Raythatha

Director/Board Member	01/03/2017	15/07/2021
Chief Executive Officer	01/03/2017	15/07/2021
President	01/03/2017	15/07/2021

Lara Smith-Weber

President	15/07/2021	-
Corporate Secretary	15/07/2021	-
Treasurer	15/07/2021	-

Jeffrey Humphrey

Chief Tech/Sci/R&D Officer

22/06/2020

15/07/2021

Patric Trojer

Chief Tech/Sci/R&D Officer

29/11/2018

15/07/2021

Elizabeth G. Trehu

Director/Board Member	04/09/2018	15/07/2021
Independent Dir/Board Member	04/09/2018	15/07/2021

James E. Audia

Director/Board Member	01/07/2017	15/07/2021
Chief Tech/Sci/R&D Officer	05/01/2011	01/07/2017
Independent Dir/Board Member	01/07/2017	15/07/2021

Karen Valentine

General Counsel

01/07/2018

15/07/2021

Emma Reeve

Comptroller/Controller/Auditor	01/10/2017	15/07/2021
Director of Finance/CFO	01/10/2017	15/07/2021
Corporate Secretary	01/12/2017	01/09/2018
Treasurer	01/12/2017	15/07/2021

Mark Goldsmith

Director/Board Member	01/07/2009	01/03/2012
Chief Executive Officer	01/07/2009	01/03/2012
Chairman	01/03/2012	15/07/2021
Independent Dir/Board Member	01/03/2012	15/07/2021
President	01/07/2009	01/03/2012

Scott Braunstein

Director/Board Member	19/02/2019	01/07/2021
Independent Dir/Board Member	19/02/2019	01/07/2021

Richard Levy

Director/Board Member	03/04/2020	01/06/2021
Independent Dir/Board Member	03/04/2020	01/06/2021

Adrian Senderowicz

Chief Tech/Sci/R&D Officer

01/07/2017

22/06/2020

Anthony Evnin

Director/Board Member	01/04/2008	31/01/2020
Independent Dir/Board Member	01/04/2008	31/01/2020

Peter Svennilson

Director/Board Member	01/06/2016	01/06/2019
Independent Dir/Board Member	01/06/2016	01/06/2019

Jessica Christo

Corporate Officer/Principal

04/03/2019

Robert J. Sims

Corporate Officer/Principal

01/06/2017

01/03/2019

Steven Hoerter

Director/Board Member	01/12/2016	01/02/2018
Independent Dir/Board Member	01/12/2016	01/02/2018
Director/Board Member	01/09/2018	15/07/2021
Independent Dir/Board Member	01/09/2018	15/07/2021

Matthias B. Jaffé

Director of Finance/CFO

01/10/2012

01/07/2017

Brad Prosek

Corporate Officer/Principal

Steven Bellon

Director/Board Member	01/09/2008	01/05/2016
Corporate Officer/Principal	01/09/2008	01/05/2016

William Amsbaugh

Director/Board Member

01/01/2012

01/07/2014

Garen Bohlin

Corporate Officer/Principal

01/01/2010

01/04/2012

Keith E. Dionne

Director/Board Member	27/03/2012	-
Chief Executive Officer	27/03/2012	-
President	27/03/2012	-

Mark Levin

Director/Board Member	19/08/2009	17/05/2010
Chairman	17/05/2010	27/03/2012
President	-	19/08/2009

Michael Cooper

Chief Tech/Sci/R&D Officer

02/02/2011

Steven Paul

Director/Board Member

02/02/2011

Kerry Reinertsen

Corporate Officer/Principal

17/05/2010

01/01/2011

Edward E. Harlow

Chief Tech/Sci/R&D Officer

17/05/2010

Cameron Wheeler

Corporate Officer/Principal

01/04/2008

01/04/2009

Robert Tepper

Director/Board Member	01/04/2008	-
Chief Tech/Sci/R&D Officer	01/04/2008	01/10/2009
Independent Dir/Board Member	01/04/2008	-

Danny Reinberg

Founder

11/01/2008

Yang Shi

Founder

11/01/2008

David Allis

Founder

11/01/2008

Tom Maniatis

Director/Board Member

David Goeddel

Director/Board Member

Joanne Schindler

Chief Tech/Sci/R&D Officer

Neil Exter

Director/Board Member	-	19/08/2009
Corporate Officer/Principal	-	-

Marc S. Rudoltz

Chief Tech/Sci/R&D Officer

Brian Gallagher

Director/Board Member

Ronald Aldridge

Investor Relations Contact

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	3
Femme	2

Dont comité exécutif

Homme	2
Femme	1

Dont Administrateurs

Homme	1
Femme	1

Constellation Pharmaceuticals, Inc. découvre et développe des petites molécules thérapeutiques pour le traitement du cancer, des troubles inflammatoires/immunologiques et d'autres maladies. La société a trois programmes de développement en oncologie en phase clinique : le premier programme évalue un composé, CPI-0610, l'autre programme évalue un composé, CPI-1205 et CPI-0209 commence l'essai clinique de phase I et cible les tumeurs solides. CPI-1205 est une petite molécule conçue pour favoriser l'activité anti-tumorale en inhibant spécifiquement l'EZH2, une enzyme qui supprime l'expression des gènes cibles. CPI-0610 est une petite molécule puissante et sélective conçue pour favoriser l'activité anti-tumorale en inhibant sélectivement la fonction des protéines BET, qui sont des protéines qui améliorent normalement l'expression des gènes cibles. La société mène l'essai ProSTAR, qui est un essai clinique ouvert de phase Ib/2 de CPI-1205 pour le traitement de la mCRPC en combinaison avec l'enzalutamide et l'acétate d'abiratérone.

Employés

154

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société